CCR3 (gene)
CCR3 or C-C chemokine receptor type 3 is a protein that in humans is encoded by the CCR3 gene. CCR3 is a member of the chemokine receptor family, and has been implicated in eosinophilic conditions such as asthma and allergic rhinitis.
Structure[edit]
The CCR3 gene is located on the third chromosome (3p21.31). The protein encoded by this gene is approximately 44 kDa in size and is composed of 7 transmembrane domains, characteristic of G protein-coupled receptors.
Function[edit]
CCR3 is a G protein-coupled receptor that functions as a receptor for chemokines. It is primarily expressed on eosinophils and basophils, and is involved in their migration to sites of inflammation. CCR3 binds to a variety of chemokines including eotaxin-1, eotaxin-2, and RANTES.
Clinical significance[edit]
Alterations in the CCR3 gene and its protein product have been associated with a variety of diseases. Overexpression of CCR3 has been observed in patients with asthma, allergic rhinitis, and other allergic diseases. In addition, CCR3 has been implicated in the pathogenesis of HIV infection, as it can function as a co-receptor for the virus.
Research[edit]
Research into the role of CCR3 in disease has led to the development of several CCR3 antagonists as potential therapeutic agents. These drugs aim to block the action of CCR3, thereby reducing eosinophil migration and inflammation.
See also[edit]
References[edit]
| Cytokine receptors | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian